According to FutureWise analysis the market for orthokeratology contact lens in 2023 is US$ 0.69 billion, and is expected to reach US$ 1.17 billion by 2031 at a CAGR of 6.7%.
Orthokeratology contact lens (also known as Ortho-K, OK, corneal reshaping, corneal refractive therapy, and vision shaping treatment) is an alternative method to correct refractive errors using custom-designed rigid lenses to temporarily modify the curvature of the cornea. Modern Ortho-K technology uses breathable rigid lens material and reverses geometry designs to allow faster and more effective corneal reshaping. Contrasting to the traditional Ortho-K designs, which use a series of progressively flattening concentric curves surrounding a central base curve fitting in alignment with the central cornea, the modern reverse geometry designs for myopia correction are characterized by a central base curve, that is, fitted significantly flatter relative to the central corneal curvature and one or more surrounding steeper secondary or “reverse” curves that enable a smooth transitioning from the flat-fitting base curve to the alignment-fitting landing curve. Currently, the most common clinical application of Ortho-K is for the reduction of myopia through corneal flattening.
According to WHO, refractory error and visual impairments can affect more 200 million people around the world. Refractive errors and visual impairments have huge impact personal well being of the general population and created a huge demand for effective treatment techniques. Rising prevalence of refractory errors among the general population boosted the demand of Orthokeratology techniques. Further, the rapid evolution of technical expertise reduced the risk factors of microbial keratitis and improved the efficiency of the process. Along with this, Orthokeratology has proven effective over the traditional method in controlling myopia progression. Further, increasing per capita healthcare expenditure of the general population has increased the adoption of orthokeratology procedures and led to the robust growth of the market. It is further supported by increasing healthcare expenditure and reimbursement policies by government bodies led to predominated growth during the forecast period.